B D Plikaytis

Summary

Affiliation: Centers for Disease Control and Prevention
Country: USA

Publications

  1. pmc Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis
    Henry M Wu
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
    BMC Infect Dis 13:26. 2013
  2. pmc An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study
    B D Plikaytis
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 38:2043-50. 2000
  3. ncbi request reprint Efficacy of meningococcal vaccine and barriers to vaccination
    N Rosenstein
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 279:435-9. 1998
  4. pmc Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay
    L L Gheesling
    Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
    J Clin Microbiol 32:1475-82. 1994
  5. pmc Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine
    S E Maslanka
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Immun 66:2453-9. 1998
  6. ncbi request reprint Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test
    K M Zangwill
    Meningitis and Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333
    N Engl J Med 329:8-13. 1993
  7. ncbi request reprint Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland
    B A Perkins
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 177:683-91. 1998
  8. ncbi request reprint Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996
    N E Rosenstein
    Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, NCID, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 32:708-15. 2001
  9. ncbi request reprint Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
    M M McNeil
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 33:641-7. 2001
  10. ncbi request reprint Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States
    A M Fry
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 188:643-52. 2003

Collaborators

  • A Schuchat
  • R A Hajjeh
  • J W Tappero
  • M M McNeil
  • D Williams
  • D Goldblatt
  • M Achtman
  • D Evans
  • J Holst
  • D L Heymann
  • B A Perkins
  • Henry M Wu
  • N E Rosenstein
  • C E Rose
  • J D Wenger
  • A M Fry
  • J A D Leake
  • Joice N Reis
  • Leonard W Mayer
  • Brian H Harcourt
  • Albert I Ko
  • Thomas A Clark
  • Jailton Azevedo
  • Stacey W Martin
  • Mariadaglorias Carvalho
  • Mitermayer G Reis
  • Katia Salgado
  • Soraia M Cordeiro
  • Mariela C Leite
  • Tainara Q Oliveira
  • C T Sacchi
  • G M Carlone
  • S E Maslanka
  • S W Martin
  • K A Wannemuehler
  • N Rosenstein
  • L L Gheesling
  • R R Facklam
  • C G Whitney
  • H Mambu Ma Disu
  • T Coulibaly
  • A Ware
  • M L Kone
  • L F Barry
  • A A Yada
  • A Berthe
  • K Esteves
  • G Traore
  • J Kawamata
  • R Talbot
  • K W Emery
  • D Rogers
  • A Kao
  • S B Werner
  • D Vugia
  • R Johnson
  • A Reingold
  • M L Tondella
  • D S Beall
  • T Popovic
  • M W Reeves
  • A M Whitney
  • L W Mayer
  • H C Campa
  • D Kapczynski
  • E A Hoiby
  • J K Dykes
  • F Sotolongo
  • E Griffiths
  • M Jones
  • K B Donaldson
  • K Jonsdottir
  • H Nokleby
  • C V Broome
  • J Bushmaker
  • O Levine
  • J Pullman
  • E Rosenqvist
  • E Tikhomirov
  • R S Brumberg
  • H Briem
  • G Sierra
  • J P Taylor
  • J Dykes
  • K M Zangwill
  • P F Holder
  • L B Pais
  • C E Frasch
  • P Densen
  • H Kayhty

Detail Information

Publications13

  1. pmc Accuracy of real-time PCR, Gram stain and culture for Streptococcus pneumoniae, Neisseria meningitidis and Haemophilus influenzae meningitis diagnosis
    Henry M Wu
    Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, CDC, Atlanta, GA 30333, USA
    BMC Infect Dis 13:26. 2013
    ..CSF Gram staining and real-time PCR are theoretically less affected by antibiotics; however, it is difficult to evaluate these tests with an imperfect reference standard...
  2. pmc An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study
    B D Plikaytis
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    J Clin Microbiol 38:2043-50. 2000
    ..While this study focused on a pneumococcal IgG ELISA, the methods that we describe are easily generalizable to other immunological assays...
  3. ncbi request reprint Efficacy of meningococcal vaccine and barriers to vaccination
    N Rosenstein
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    JAMA 279:435-9. 1998
    ..Use of the quadrivalent meningococcal vaccine for control of outbreaks has increased in recent years, but the efficacy of meningococcal vaccine during mass vaccination campaigns in US civilian populations has not been assessed...
  4. pmc Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay
    L L Gheesling
    Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
    J Clin Microbiol 32:1475-82. 1994
    ..The acceptance and use of this standardized ELISA will reduce between-laboratory assay variability and ensure a more accurate and reproducible assessment of immunogenicity for vaccines under development...
  5. pmc Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine
    S E Maslanka
    Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    Infect Immun 66:2453-9. 1998
    ..The bactericidal results show age-dependent differences in the production and retention of antibody in young children immunized with serogroup C polysaccharide; these differences are not evident with the ELISA data...
  6. ncbi request reprint Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test
    K M Zangwill
    Meningitis and Special Pathogens Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333
    N Engl J Med 329:8-13. 1993
    ....
  7. ncbi request reprint Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland
    B A Perkins
    Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 177:683-91. 1998
    ..10% and 1% [control]) or the Finlay Institute vaccine group (P < .05 for both). SBA and ELISA may be insensitive correlates for protective efficacy for some outer membrane protein-based serogroup B meningococcal vaccines...
  8. ncbi request reprint Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996
    N E Rosenstein
    Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, NCID, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 32:708-15. 2001
    ..Persons at risk for severe CM may benefit from vaccination once an effective CM vaccine is available...
  9. ncbi request reprint Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997
    M M McNeil
    Mycotic Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
    Clin Infect Dis 33:641-7. 2001
    ..These data highlight the public health importance of mycotic diseases and emphasize the need for continuing surveillance...
  10. ncbi request reprint Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States
    A M Fry
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA
    J Infect Dis 188:643-52. 2003
    ..HIV/AIDS was not an independent risk factor for TMP-SMZ nonsusceptibility. Vulnerability to certain serotypes among adults with HIV/AIDS may have implications in prevention strategies...
  11. ncbi request reprint On the use of zero-inflated and hurdle models for modeling vaccine adverse event count data
    C E Rose
    Bacterial Vaccine Preventable Diseases Branch, Division of Epidemiology and Surveillance, CDC, Atlanta, Georgia 30333, USA
    J Biopharm Stat 16:463-81. 2006
    ..at-risk participants) then the hurdle model framework is generally preferred. Conversely, if the study's primary purpose it is to develop a prediction model then both the zero-inflated and hurdle modeling frameworks should be adequate...
  12. ncbi request reprint Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998
    C T Sacchi
    Meningitis and Special Pathogens Branch, Mail Stop D 11, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    J Infect Dis 182:1169-76. 2000
    ..Studies are needed to fully evaluate the extent of cross-protection in humans among the variants and prototypes in each PorA VR family...
  13. pmc Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy
    J A D Leake
    Centers for Disease Control and Prevention, Atlanta, Georgia, USA
    Bull World Health Organ 80:342-9. 2002
    ....